Nizatidine
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Nizatidine is an antihistamine that blocks H2 receptor activity.[1][2] Nizatidine is used to treat ulcers and gastroesophageal reflux disease (GERD), plus heartburn.[1][2]
Nizatidine is marketed under different brand names Axid AR, Axid Pulvules.[1][2]
Theory[edit | edit source]
Evidence[edit | edit source]
Some evidence exists from a small observational study of Long COVID patients by Glynne et al. (2022).[3]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Costs and availability[edit | edit source]
Nizatidine is perscription only abd available as an oral capsule, tablet, or oral solution.[1][2]
Notable studies[edit | edit source]
- 2022, Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines[3] - (Full text)
See also[edit | edit source]
Learn more[edit | edit source]
- Nizatidine - DrugBank Online
- Nizatidine - drugs.com
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 "Nizatidine Uses, Dosage & Side Effects". Drugs.com. Retrieved February 19, 2022.
- ↑ 2.0 2.1 2.2 2.3 "Nizatidine: Uses, Interactions, Mechanism of Action". Drugbank Online. Retrieved February 19, 2022.
- ↑ 3.0 3.1 Glynne, Paul; Tahmasebi, Natasha; Gant, Vanya; Gupta, Rajeev (January 2022). "Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines". Journal of Investigative Medicine. 70 (1): 61–67. doi:10.1136/jim-2021-002051. ISSN 1081-5589. PMC 8494538. PMID 34611034.
